Dx dialogues: other potential treatments for indolent systemic mastocytosis

In addition to avapritinib, Sanjay Juneja, MD, walks you through other potential treatment options for indolent systemic mastocytosis

Although it’s not the most common cancer, it is among the most deadly. Here’s why—and why there’s hope for future treatments.

Newer estimates reflect major progress against common cancers. Find out why, and how you can protect yourself.

Learn the different ways kidney cancer can cause pain and how pain can be managed.

While much of your cancer risk is out of your hands, you may be able to lower your odds by managing your weight.

An overview of hospice care, including the benefits it can offer and basic strategies for finding hospice care.